Similar articles

• Chemotherapy and hormone therapy of metastatic breast cancer.

  Paterson AH. Paterson AH. Southeast Asian J Trop Med Public Health. 1985 Dec;16(4):631-3. Southeast Asian J Trop Med Public Health. 1985. PMID: 3835708 No abstract available.
• [UFT-MT therapy in advanced or recurrent breast cancer].

  Yamaguchi S, Komoriyama H, Tsukikawa S, Imaki S, Morikubo M, Asakura T, Okamura R, Fukuda M, Kanasugi K, Watanabe H. Yamaguchi S, et al. Gan To Kagaku Ryoho. 1990 Dec;17(12):2437-41. Gan To Kagaku Ryoho. 1990. PMID: 2124435 Japanese. No abstract available.
• [Endocrine therapy in breast carcinoma].

  Dogliotti L, Maschietto M, Ortega C. Dogliotti L, et al. Minerva Chir. 1988 Sep 30;43(18 Suppl):63-6. Minerva Chir. 1988. PMID: 3067123 Italian. No abstract available.
• Adjuvant systemic therapy in primary breast cancer.

  Mouridsen HT, Palshof T. Mouridsen HT, et al. Acta Chir Scand Suppl. 1984;519:43-53. Acta Chir Scand Suppl. 1984. PMID: 6393664 Review. No abstract available.
• [Adjuvant therapy of breast cancer].

  Semiglazov VF, Abzumanov AS, Bozhok AA, Ivanov VG, Ivanova OA, Barash NIu, Topuzov EE, Seleznev IK, Migmanova NSh, Popova RT, Nurgaziev KSh. Semiglazov VF, et al. Khirurgiia (Mosk). 2001;(5):52-60. Khirurgiia (Mosk). 2001. PMID: 11505673 Review. Russian. No abstract available.